San Diego, CA, United States of America

Yao Li

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yao Li. Retrieved from https://idiyas.com/inventor/yao-li-h84d631q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yao Li: Innovator in Cyclic Dinucleotide Compounds

Introduction

Yao Li is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on cyclic dinucleotide compounds.

Latest Patents

Yao Li holds a patent for "Cyclic dinucleotide compounds as STING agonists." This patent discloses cyclic dinucleotides that are useful as STING agonists, along with pharmaceutical compositions and vaccines that incorporate these compounds. The methods outlined in the patent aim to treat various diseases and disorders using these cyclic dinucleotides, pharmaceutical compositions, and vaccines.

Career Highlights

Yao Li is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its potential applications in medicine and therapeutic interventions.

Collaborations

Yao Li has collaborated with notable colleagues, including Yitzhak Tor and Andrea Fin, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yao Li's contributions to the field of cyclic dinucleotide compounds highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…